Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical tranexamic acid injection to reduce bleeding during and after tonsillectomy (15–45 years)
IRCT20211028052900N2Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tranexamic acid in perioperative hemorrhage, sponsored by Isfahan University of Medical Sciences. Primary endpoints: Intraoperative bleeding volume and Postoperative bleeding incidence. Started Apr 2022; status: completed.
02
Drugs
tranexamic acid
03
Conditions
perioperative hemorrhage
Beyond the preview
Go deeper on IRCT20211028052900N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211028052900N2.